Ibogaine
Ibogaine (12-methoxyibogamine)
12-24 hours (full experience), residual effects 2-3 days
1-3 hours
dissociative
Found in the root bark of the Tabernanthe iboga shrub, nativ…
- ⚡Waking dream states lasting 12-24 hours — vivid, narrative visions
- ⚡Intense life review — autobiographical memories replayed in detail
- ⚡Deep introspection and confrontation with repressed psychological content
- ⚡Anti-addiction properties — resets opioid receptors and dopamine pathways
- ⚡Emotional processing and trauma resolution
- ⚡Perceived communication with spiritual guides or ancestors
- ⚠️Cardiotoxicity is the primary risk — potential for fatal cardiac arrhythmia
- ⚠️Full medical screening including EKG required before any use
- ⚠️Multiple deaths recorded in unsupervised settings — medical supervision is non-negotiable
- ⚠️Contraindicated with heart conditions, QT-prolonging drugs, and liver disease
- ⚠️Dangerous interactions with opioids, stimulants, and many psychiatric medications
- ⚠️Should only be undertaken in medically supervised settings with cardiac monitoring equipment on site
Sacred medicine of the Bwiti spiritual tradition of the Fang and Mitsogo peoples of Gabon and Cameroon. Used in multi-day initiation ceremonies involving intense introspective journeys, communal dancing, and direct communication with ancestors. The Bwiti consider iboga the 'tree of knowledge' and the foundation of their entire spiritual practice. Traditional doses can be far higher than therapeutic ones.
Landmark 2024 Stanford study showed ibogaine dramatically reduced PTSD and TBI symptoms in veterans (88% reduction at 1 month). Multiple legal clinics in Mexico and New Zealand. DARPA and VA both funding research. FDA Breakthrough Therapy designation being pursued.
Schedule I in the US. Illegal in most Western countries. Legal for therapeutic use in New Zealand (by prescription). Legal in Mexico and Brazil where ibogaine clinics operate. Traditional use protected in Gabon.